Loading clinical trials...
Loading clinical trials...
Disease Characteristics of Inflammation-associated Rapidly-progressive Coronary Artery Disease (IR-CAD): a Case-control Study
Conditions
Interventions
Protocol-defined Examinations
Locations
1
China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Start Date
November 2, 2023
Primary Completion Date
September 1, 2026
Completion Date
September 1, 2026
Last Updated
November 19, 2025
NCT07329699
NCT06863155
NCT06779630
NCT05461729
NCT07493603
NCT03854071
Lead Sponsor
Peking Union Medical College Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions